Hualan Biological Bacterin Inc. (301207.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.08B |
| Enterprise Value | 10.74B |
| P/E Ratio | 195.23 |
| PEG Ratio | -5.53 |
| Price/Sales Ratio | 12.93 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 12.11 |
| Enterprise/EBITDA | 102.69 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | -0.1 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 1.2B |
| Revenue/Share | 1.17 |
| Gross Profit | 893.76M |
| EBITDA | 331.64M |
| Net Income | 182.92M |
| Diluted EPS | 0.31 |
Balance Sheet
| Total Cash | 2.09B |
| Total Cash/Share | 3.52 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.63 |
| Book Value Per Share | 8.68 |
Price History
| 52-Week Change | -36.77 |
| 52-Week High | 27.88 |
| 52-Week Low | 13.66 |
| Moving Average 50 Days | 18.02 |
| Moving Average 200 Days | 18.59 |
Statistics
| Average Volume | 9.04M |
| Shares Outstanding | 595M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.4 |
| Trailing Annual Dividend Yield | 9.24 |
| Payout Ratio | 19.22 |
| Last Split Factor | 3:2 |
| Last Split Date | June 07, 2023 |
AD
